Colgate-Palmolive (India) Limited (BOM:500830)
| Market Cap | 560.37B -19.2% |
| Revenue (ttm) | 60.35B -0.1% |
| Net Income | 13.25B -7.8% |
| EPS | 48.73 -7.8% |
| Shares Out | 271.99M |
| PE Ratio | 42.28 |
| Forward PE | 38.62 |
| Dividend | 48.00 (2.33%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 38,470 |
| Open | 2,090.75 |
| Previous Close | 2,087.20 |
| Day's Range | 2,052.00 - 2,107.55 |
| 52-Week Range | 1,781.60 - 2,507.20 |
| Beta | 0.56 |
| Analysts | Hold |
| Price Target | 2,263.70 (+9.87%) |
| Earnings Date | May 22, 2026 |
About Colgate-Palmolive (India)
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India. [Read more]
Financial Performance
In fiscal year 2026, Colgate-Palmolive (India)'s revenue was 60.35 billion, a decrease of -0.08% compared to the previous year's 60.40 billion. Earnings were 13.25 billion, a decrease of -7.76%.
Financial StatementsNews
Colgate-Palmolive (India) Transcript: Q4 25/26
Q4 saw 9% sales growth and strong margins, with premiumization and innovation driving performance. Full-year sales were flat, but H2 showed recovery. Premium brands, e-commerce, and sustainability initiatives are key growth drivers.
Colgate-Palmolive (India) Quarterly report: Q4 2026
Colgate-Palmolive (India) has published its Q4 2026 quarterly earnings report on May 22, 2026.
Colgate-Palmolive (India) Slides: Q4 2026
Colgate-Palmolive (India) has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 22, 2026.
Stocks to watch today, Jan 30: Godrej Properties, ACME Solar, Aurobindo Pharma, Voltas, Colgate-Palmolive India and more
Indian equity markets are likely to see stock-specific action on Friday, January 30, as several companies announced key business updates...
Colgate-Palmolive (India) Quarterly report: Q3 2026
Colgate-Palmolive (India) has published its Q3 2026 quarterly earnings report on January 29, 2026.
Colgate-Palmolive India receives Rs 267.64 crore income tax demand for FY22; company to file appeal
Colgate-Palmolive (India) Limited has received an assessment order from the Income Tax Department raising a demand of Rs 267.64 crore...
Colgate-Palmolive India shares fall over 3% after Q2 net profit drops 17% YoY to Rs 328 crore
Colgate-Palmolive (India) Ltd shares slipped more than 3% on Friday after the company announced its financial results for the second...
Colgate-Palmolive (India) Quarterly report: Q2 2026
Colgate-Palmolive (India) has published its Q2 2026 quarterly earnings report on October 22, 2025.
Colgate-Palmolive (India) Quarterly report: Q1 2026
Colgate-Palmolive (India) has published its Q1 2026 quarterly earnings report on July 27, 2025.
Top brokerages on Colgate share: Citi, HSBC, GS bearish post Q1 miss; Nuvama expects H2 recovery
Colgate-Palmolive India’s Q1FY26 results have triggered a range of reactions from brokerages, with target prices spanning from as low as ₹2,175 to as high as ₹3,135. While most firms have cited weak d...
Citi maintains sell on Colgate, trims target to Rs 2,175 citing competition and muted demand
Citi has reiterated its Sell rating on Colgate-Palmolive India and reduced the target price from ₹2,300 to ₹2,175 per share, citing continued pressure from weak urban demand and heightened competitive...
Colgate share: Goldman Sachs maintains sell, sees downside with ₹2,300 target after weak Q1 and earnings cut
Goldman Sachs has reiterated its Sell rating on Colgate-Palmolive India and set a target price of ₹2,300 per share, implying a downside from the current market price of ₹2,375.90. The brokerage highli...
Colgate-Palmolive (India) Q1 Results: Net profit slips 11.8% YoY to Rs 321 crore, revenue down 2%
Colgate-Palmolive (India) Ltd. reported its financial results for the first quarter of FY26, showing a dip in both profit and revenue compared to the same period last year. The company’s net profit dr...
Colgate share: UBS maintains buy with Rs 3,000 target, sees attractive risk-reward despite near-term softness
UBS has reiterated a buy rating on Colgate-Palmolive India, setting a target price of ₹3,000 per share, as it views current cyclical weakness as a buying opportunity with strong long-term structural p...
Colgate-Palmolive (India) Transcript: Q4 24/25
FY2024-25 saw 6.5% revenue growth, strong margins, and robust premiumization, despite a Q4 revenue dip and soft urban demand. Rural and premium segments outperformed, with major product launches and continued high brand investment.
Colgate-Palmolive (India) Annual report: Q4 2025
Colgate-Palmolive (India) has published its Q4 2025 annual report on May 22, 2025.
Colgate-Palmolive (India) Quarterly report: Q4 2025
Colgate-Palmolive (India) has published its Q4 2025 quarterly earnings report on May 22, 2025.
Colgate-Palmolive (India) Slides: Q4 2025
Colgate-Palmolive (India) has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on May 22, 2025.
Colgate-Palmolive shares decline nearly 4% as Q4 net profit drops 6.5%, misses street estimates
Shares of Colgate-Palmolive (India) Ltd fell 3.97% to ₹2,553.70 on Thursday, following the announcement of its Q4FY25 results which showed weaker-than-expected earnings. The stock had closed at ₹2,659...
Goldman Sachs maintains ‘Sell’ on Colgate-Palmolive; Q4 EBITDA margins disappoint
Goldman Sachs has maintained a ‘Sell’ rating on Colgate-Palmolive (India) Ltd, with a target price of ₹2,630, following the company’s Q4 FY25 earnings that reflected pressure on revenue and profitabil...
Stock in focus: Colgate-Palmolive Q4 profit declines 6.5% YoY to Rs 355 crore; revenue and margin slip
Shares of Colgate-Palmolive (India) Ltd will be in focus today, May 22, after the FMCG major reported a weaker-than-expected performance in its Q4 FY25 earnings announced post-market hours on Tuesday....
Citi maintains ‘Sell’ on Colgate, cuts target to Rs 2,600 citing competitive pressures
Citi has reiterated its Sell rating on Colgate-Palmolive (India) Ltd, lowering its target price to ₹2,600 from the previous ₹3,000, citing increased competitive pressures and higher promotional intens...
Colgate-Palmolive (India) Quarterly report: Q3 2025
Colgate-Palmolive (India) has published its Q3 2025 quarterly earnings report on January 28, 2025.
Colgate shares rise 2.27% post investor day; brokerages remain mixed on growth outlook
Shares of Colgate Palmolive (India) Ltd. (NSE: COLPAL) gained 2.27% in early trading on November 28, reaching ₹3,085.95. The surge comes after the company’s Investor Day, where management outlined its...
Colgate-Palmolive (India) Transcript: Investor Day 2024
Consistent double-digit growth, strong brand metrics, and robust margins are underpinned by a four-pillar strategy: category expansion, premiumization, toothbrush/device leadership, and personal care diversification. Major initiatives include AI-driven dental screening, expanded school programs, and tech-enabled execution, with premiumization and innovation driving future growth.